Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2025 Earnings Call Transcript May 8, 2025
Crinetics Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.04 EPS, expectations were $-0.99.
Operator: And the call will begin shortly. Please press star followed by one on your telephone keypad. If you change your mind, please press star followed by two. Thank you. At this time, all participants are in listen-only mode. Following the management’s prepared remarks, we will...
